BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 17644872)

  • 1. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Hamilton-Persaud K; Ezell LD; Macklin JG
    Nephrol Nurs J; 2007; 34(3):283-7; quiz 288. PubMed ID: 17644872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
    Grobner T
    Nephrol Dial Transplant; 2006 Apr; 21(4):1104-8. PubMed ID: 16431890
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nephrogenic fibrosing dermopathy].
    Engelen JW; Kooistra MP; Canninga-van Dijk MR; Toonstra J; Sigurdsson V
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2435-8. PubMed ID: 14694555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrogenic fibrosing dermopathy.
    Firoz BF; Hunzeker CM; Soldano AC; Franks AG
    Dermatol Online J; 2008 May; 14(5):11. PubMed ID: 18627747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong association between the use of gadolinium-based contrast agents with nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Jamboti J
    Intern Med J; 2007 Jul; 37(7):508-9; author reply 509. PubMed ID: 17547734
    [No Abstract]   [Full Text] [Related]  

  • 6. Nephrogenic systemic fibrosis in advanced chronic kidney disease: a single hospital's experience in Taiwan.
    Chen W; Huang SL; Huang CS; Tsai MC; Lai HM; Lui CC; Eng HL; Chang HW; Lee CH; Chuang FR
    Eur J Dermatol; 2009; 19(1):44-9. PubMed ID: 19059824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis in 2 patients with end-stage renal disease on hemodialysis.
    Kim RH; Ma L; Hayat SQ; Ahmed MM
    J Clin Rheumatol; 2006 Jun; 12(3):134-6. PubMed ID: 16755242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrogenic systemic fibrosis, in patients with end-stage kidney disease on dialysis, in the greater Auckland region, from 2000-2006.
    Kendrick-Jones JC; Voss DM; De Zoysa JR
    Nephrology (Carlton); 2011 Feb; 16(2):243-8. PubMed ID: 21272139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature.
    Lim YL; Lee HY; Low SC; Chan LP; Goh NS; Pang SM
    Clin Exp Dermatol; 2007 Jul; 32(4):353-8. PubMed ID: 17433041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: a primer for radiologists.
    Prasad SR; Jagirdar J
    J Comput Assist Tomogr; 2008; 32(1):1-3. PubMed ID: 18303280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrogenic systemic fibrosis: an overview.
    Cowper SE
    J Am Coll Radiol; 2008 Jan; 5(1):23-8. PubMed ID: 18180005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrogenic fibrosing dermopathy associated with exposure to gadolinium-containing contrast agents--St. Louis, Missouri, 2002-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Feb; 56(7):137-41. PubMed ID: 17318112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure.
    Kucher C; Steere J; Elenitsas R; Siegel DL; Xu X
    J Am Acad Dermatol; 2006 Feb; 54(2 Suppl):S31-4. PubMed ID: 16427988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrogenic systemic fibrosis: is gadolinium to be blamed?
    Jikki PN
    J Assoc Physicians India; 2008 Nov; 56():915-6. PubMed ID: 19263697
    [No Abstract]   [Full Text] [Related]  

  • 15. Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy).
    Galan A; Cowper SE; Bucala R
    Curr Opin Rheumatol; 2006 Nov; 18(6):614-7. PubMed ID: 17053507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrogenic fibrosing dermopathy: report of two cases.
    Aires NB; Sotto MN; Nico MM
    Acta Derm Venereol; 2007; 87(6):521-4. PubMed ID: 17989891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmetallation and gadolinium: do low iron stores prevent the development of nephrogenic systemic fibrosis in high-risk end-stage renal disease patients?
    Panesar M; Boateng F; Patel SS; Masood SF; Mahajan P; Patel N; Murray B
    Hemodial Int; 2010 Jul; 14(3):289-94. PubMed ID: 20662951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium deposition in nephrogenic fibrosing dermopathy.
    Boyd AS; Zic JA; Abraham JL
    J Am Acad Dermatol; 2007 Jan; 56(1):27-30. PubMed ID: 17109993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: a case series of nine patients and review of the literature.
    Introcaso CE; Hivnor C; Cowper S; Werth VP
    Int J Dermatol; 2007 May; 46(5):447-52. PubMed ID: 17472669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal photopheresis improves nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: three case reports and review of literature.
    Mathur K; Morris S; Deighan C; Green R; Douglas KW
    J Clin Apher; 2008; 23(4):144-50. PubMed ID: 18633995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.